Cymbalta, manufactured by American pharmaceutical giant Eli Lilly, is a medicine which is used widely to treat a variety of psychiatric disorders including major depressive disorder, generalised anxiety disorder, fibromyalgia and neuropathic pain. Developed by Eli Lilly in the 1980's, Cymbalta is a thiophene derivative that works as a selective reuptake inhibitor of serotonin, norepinephrine and dopamine. By increasing levels of all three of these neurotransmitters, Cymbalta can improve a patient's sense of vitality and overall happiness.
Cymbalta has been used clinically for several decades now and is actually recommended as a first line treatment for specific conditions now including neuropathy caused by chemotherapy, and in fibromyalgia. However, its merits compared to other medicines will ultimately be dependent on the patient's specific history.
Cymbalta is only licensed for use in adults however it has been prescribed by some doctors for patients under the age of 18 but it is generally not recommended to do so.
Cymbalta doses tend to vary based on the condition with depression usually dosed at a starting dose of 60mg once a day and anxiety at 30mg once a day. However, it is extremely important that the patient defer to their doctor's specific advice on dosing. Always refer to product literature